DELRAY BEACH, Fla., May 24, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID”) (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that it has completed its acquisition of MicroFluidic Systems (“MFSI”). Founded in 2001, MFSI specializes in the production of automated instruments for a wide range of applications in the detection and processing of biological samples. MFSI’s strong portfolio of intellectual property related to sample preparation and rapid medical testing applications are complementary to PositiveID’s portfolio of virus detection and diabetes management products. MFSI has received over $45 million in government contracts, the majority of which have come from the Department of Homeland Security.
